These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8156205)
1. Japanese GLP initiatives. Nomura A Qual Assur; 1993; 2(1-2):16-20. PubMed ID: 8156205 [No Abstract] [Full Text] [Related]
2. The regulation of biopharmaceuticals. Weisbroth N Qual Assur; 1993; 2(1-2):147-51. PubMed ID: 8156202 [No Abstract] [Full Text] [Related]
3. Bioequivalence/bioavailability retention samples. Ransom C Qual Assur; 1993; 2(1-2):42-3. PubMed ID: 8156218 [No Abstract] [Full Text] [Related]
4. French GLP initiatives and SoFAQ. Lowing R Qual Assur; 1993; 2(1-2):21-6. PubMed ID: 8156215 [No Abstract] [Full Text] [Related]
5. Japanese authority GLP inspections for pharmaceuticals and agrochemicals. Preparing for and handling agency inspections. Iwaoka T Qual Assur; 1995 Jun; 4(2):139-42. PubMed ID: 8720158 [TBL] [Abstract][Full Text] [Related]
6. A simple key to EPA's GLP regulation advisories. Vance B Qual Assur; 1993; 2(1-2):183-5. PubMed ID: 8156210 [No Abstract] [Full Text] [Related]
7. The French GLP and GCP inspections and agencies plus an overview of GLP and GCP inspections and agencies in Eastern and Central Europe. Dent NJ Qual Assur; 1995 Jun; 4(2):127-34. PubMed ID: 8720156 [No Abstract] [Full Text] [Related]
8. EPA's GLP compliance review of chemistry laboratories. Hill DF Qual Assur; 1993; 2(1-2):78-84. PubMed ID: 8156226 [TBL] [Abstract][Full Text] [Related]
10. The critical phase inspection process: a benchmarking study in search of industries' best practices. Herman DR; Dangler TL; Houser DA; Lewis TG; Masten JL; Taylor IE Qual Assur; 1993; 2(1-2):186-90. PubMed ID: 8156211 [TBL] [Abstract][Full Text] [Related]
11. FDA state of affairs. Lepore P Qual Assur; 1993; 2(1-2):156-61. PubMed ID: 8156204 [No Abstract] [Full Text] [Related]
12. Managed care. States move to tighten their grip on HMOs. Rose JR Med Econ; 1999 Nov; 76(22):34. PubMed ID: 10787711 [No Abstract] [Full Text] [Related]
13. Overview of field studies. Henry L; Henry H Qual Assur; 1993; 2(1-2):32-8; discussion 39-41. PubMed ID: 8156217 [No Abstract] [Full Text] [Related]
14. EPA state of affairs. Dull D Qual Assur; 1993; 2(1-2):162-8. PubMed ID: 8156206 [No Abstract] [Full Text] [Related]
15. Good Automated Laboratory Practices. Weinberg S Qual Assur; 1993; 2(1-2):62-6. PubMed ID: 8156223 [No Abstract] [Full Text] [Related]
16. Inspection of a metabolism study. Carson RC Qual Assur; 1993; 2(1-2):85-91. PubMed ID: 8156227 [No Abstract] [Full Text] [Related]
17. [Quality in nursing homes]. Haizmann JJ; Clerc AO Rev Med Suisse Romande; 2000 Nov; 120(11):897-902. PubMed ID: 11140309 [TBL] [Abstract][Full Text] [Related]
18. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry]. Ebi O Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232 [TBL] [Abstract][Full Text] [Related]
19. Quality assurance, corporate compliance, and risk management: overlapping but not identical tools. Sollins HL Geriatr Nurs; 2008; 29(3):157-9. PubMed ID: 18555156 [No Abstract] [Full Text] [Related]
20. [Standardization and quality in the clinical laboratory : towards an European system of clinical laboratory sciences]. Fuentes-Arderiu X Ann Biol Clin (Paris); 2001; 59(2):225-30. PubMed ID: 11282529 [No Abstract] [Full Text] [Related] [Next] [New Search]